April 13, 2022
Jeito Capital Co-Leads $76 Million Series A Financing for CDR-Life, its 10th Investment Since its Launch
Jeito Capital (“Jeito”), a leading independent Private Equity firm dedicated to biotech and biopharma, announced today that it has co-led a $76 million Series A financing round in CDR-Life, a privately-held biotech company developing a new generation of immuno-oncology therapies.